Literature DB >> 12193365

New trial should clarify lithium use in bipolar disorder.

John Geddes, Guy Goodwin, Jennifer Rendell, Jane Hainsworth, Emma Van der Gucht, Heather Young.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12193365      PMCID： PMC1123948     

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  5 in total

1.  Lithium in bipolar mood disorder.

Authors:  Timothy G Dinan
Journal:  BMJ       Date:  2002-04-27

2.  Evidence-based psychiatry--do psychiatrists want it and can they do it?

Authors:  S M Lawrie; A I Scott; M C Sharpe
Journal:  Health Bull (Edinb)       Date:  2000-01

3.  BALANCE: a large simple trial of maintenance treatment for bipolar disorder.

Authors:  John R Geddes; Jennifer M Rendell; Guy M Goodwin
Journal:  World Psychiatry       Date:  2002-02       Impact factor: 49.548

Review 4.  Lithium for maintenance treatment of mood disorders.

Authors:  S Burgess; J Geddes; K Hawton; E Townsend; K Jamison; G Goodwin
Journal:  Cochrane Database Syst Rev       Date:  2001

Review 5.  Bipolar disorder: clinical uncertainty, evidence-based medicine and large-scale randomised trials.

Authors:  J Geddes; G Goodwin
Journal:  Br J Psychiatry Suppl       Date:  2001-06
  5 in total
  3 in total

1.  Older patients are eligible for trial of lithium and valproate.

Authors:  Jennifer M Rendell; John R Geddes; Michael J Ostacher
Journal:  BMJ       Date:  2003-08-16

2.  Bringing a research base to psychiatry.

Authors:  Miriam Shuchman; Paul C Hébert; Rajendra Kale; Barbara Sibbald; Ken Flegel; Noni MacDonald
Journal:  CMAJ       Date:  2008-05-06       Impact factor: 8.262

3.  Multisite, open-label, prospective trial of lamotrigine for geriatric bipolar depression: a preliminary report.

Authors:  Martha Sajatovic; Ariel Gildengers; Rayan K Al Jurdi; Laszlo Gyulai; Kristin A Cassidy; Rebecca L Greenberg; Martha L Bruce; Benoit H Mulsant; Thomas Ten Have; Robert C Young
Journal:  Bipolar Disord       Date:  2011-05       Impact factor: 6.744
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.